Bone Density
The Bone Truth: Why Physiologic Hormone Restoration Works
By James Nagel, MD
As a physician who has been practicing Physiologic Hormone Restoration Therapy (PHRT®) for many years, I’ve seen firsthand how this approach doesn’t just improve symptoms—it changes lives. One of the most powerful and consistent areas of success I’ve witnessed is in bone health. I want to share what we know, what we see, and why this matters—especially for women navigating midlife and beyond.

Bone Density Isn’t Just About Calcium
The narrative we’ve all heard is that osteoporosis is an inevitable part of aging. For decades, we’ve been told to increase calcium intake, supplement with vitamin D, and consider bisphosphonates or other bone medications to preserve what we can.
But here’s the truth: those interventions alone are not enough. In my experience, what truly builds bone is restoring the hormonal environment that supports dynamic bone remodeling—especially the estrogen and progesterone cycles that occur in a healthy, reproductive woman.
This is where PHRT® differs from static hormone therapy. PHRT® doesn’t just deliver estrogen and progesterone. It mimics the natural rhythm of a woman’s cycle, delivering these hormones in a dynamic, time-coordinated way that mirrors what the ovaries used to produce. This rhythm is critical—not just for symptom relief, but for the health of your bones, your brain, your immune system, and beyond.
The Science: Why Rhythm Matters
Your bones aren’t static—they’re living tissue, constantly undergoing remodeling. That process is deeply influenced by hormonal signaling. Estrogen plays a critical role in protecting bones from breakdown, while progesterone helps stimulate bone-building activity through osteoblast activation. The rhythm of these hormones—how they rise and fall over the course of a cycle—is key to keeping bone turnover in balance.
In menopause, when that rhythm disappears, bone remodeling skews toward breakdown. That’s why we see an average of 1–2% loss in bone density per year in postmenopausal women. Medications can slow this loss, but they rarely result in meaningful gains—unless we stimulate the system the way nature intended.
One Case, Thousands of Stories
Let me share just one example—among hundreds of similar cases I’ve seen.
A 61-year-old patient of mine has been following the PHRT® protocol for 11 years. Her most recent DEXA scan, taken in January 2025, shows a lumbar spine bone mineral density (BMD) of 1.316 g/cm² with a T-score of 0.5. That’s 126% of normal. For reference, a T-score between -1.0 and +1.0 is considered normal. This patient is not just maintaining her bone health—she’s improving it as she ages.
And she’s not alone.
We’ve seen women in their 70s and 80s not only halt bone loss, but build new bone. Women who were once diagnosed with osteoporosis—some with T-scores in the -3.0 range—now have T-scores approaching or even surpassing zero. This level of improvement is unheard of with standard static, low dose hormone regimens or bisphosphonate therapy.
The Role of the Immune System and RANKL
Bone health is not just about hormones—it’s also intricately tied to the immune system. One of the key players in bone remodeling is the RANKL/RANK/OPG system. Estrogen stimulates the production of osteoprotegerin (OPG), a molecule that helps prevent excessive bone breakdown. Without enough estrogen, RANKL runs unchecked, leading to more bone resorption.
Progesterone also activates RANKL, but in a way that supports the normal remodeling cycle—helping to clear old bone and make room for new bone to be built. The synergy between these hormones, especially when delivered in physiologic rhythm, is what supports true bone health—not just maintenance, but growth.
What About Vitamin D and K2?
These nutrients matter. They’re important cofactors, and I always check for deficiencies and recommend supplementation when appropriate. But in isolation, they’re not enough. Without restoring the hormonal signaling that governs bone turnover, we’re only addressing a piece of the puzzle.
A Paradigm Shift in Osteoporosis Care
This is a call to rethink how we view hormone therapy—not as symptom management, but as a foundational, regenerative treatment. We have decades of research showing that estrogen helps prevent bone loss. Add progesterone in rhythm, and we shift from prevention to regeneration.
PHRT® isn’t a theory anymore. It’s a practiced, observed, and measured method that consistently shows remarkable outcomes in real patients, including my own.
Final Thoughts
I believe every woman deserves to age with strength, clarity, and vitality. For many of my patients, PHRT® has restored not just their bone density, but their energy, mood, sleep, and sense of well-being. This therapy is not just about hormones—it’s about restoring a biological rhythm that the body recognizes, responds to, and thrives on.
If you’re a practitioner, I invite you to learn more. If you’re a patient, ask your doctor about rhythmic hormone restoration. Don’t settle for slow decline when vibrant health is possible.



